Neuro-Oncology Reviews
Volume
22 Number 8
30 April 2020
Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 8, 30 April
Azzarelli
R.
Organoid
Models of Glioblastoma to Study Brain Tumor Stem Cells.
Front
Cell Dev Biol. 2020 Apr 16;8:220→.
doi: 10.3389/fcell.2020.00220→.
PMID: 32373607→.
Review.
ˍ
Fountas
KN.
Fluorescent
Guided Surgery in the Surgical Management of Glioma: The Dawn of a
New Era.
Brain
Sci. 2020 Apr 16;10(4):E237→.
doi: 10.3390/brainsci10040237→.
PMID: 32316309→.
Editorial.
ˍ
Laigle-Donadey
F, Greffard S.
Management
of glioblastomas in the elderly population.
Rev
Neurol
(Paris).
2020 Apr 16;176(9):724-732→.
doi: 10.1016/j.neurol.2020.01.362→.
PMID: 32307112→.
Review.
ˍ
Sanders
S, Debinski W.
Challenges
to Successful Implementation of the Immune Checkpoint Inhibitors
for Treatment of Glioblastoma.
Int
J Mol Sci. 2020 Apr 16;21(8):E2759→.
doi: 10.3390/ijms21082759→.
PMID: 32316096→.
Review.
ˍ
Li
J, Zhao J, Tan T, Liu M, Zeng Z, Zeng Y, Zhang L, Fu C, Chen D,
Xie T.
Nanoparticle
Drug Delivery System for Glioma and Its Efficacy Improvement
Strategies: A Comprehensive Review.
Int
J Nanomedicine. 2020 Apr 17;15:2563-2582→.
doi: 10.2147/IJN.S243223→.
PMID: 32368041→.
Review.
ˍ
Majd
N, Dasgupta P, de Groot J.
Immunotherapy
for Neuro-Oncology.
Adv
Exp Med Biol. 2020 Apr 17;1244:183-203→.
doi: 10.1007/978-3-030-41008-7_8→.
PMID: 32301015→.
Review.
ˍ
Ruff
M, Kizilbash S, Buckner J.
Further
understanding of glioma mechanisms of pathogenesis: implications
for therapeutic development.
Expert
Rev Anticancer Ther. 2020 Apr 17;20(5):355-363→.
doi: 10.1080/14737140.2020.1757440→.
PMID: 32301635→.
Review.
ˍ
Birch
JL, Coull BJ, Spender LC, Watt C, Willison A, Syed N, Chalmers AJ,
Hossain-Ibrahim MK, Inman GJ.
Multifaceted
transforming growth factor-beta (TGFβ) signalling in
glioblastoma.
Cell
Signal. 2020 Apr 19;72:109638→.
doi: 10.1016/j.cellsig.2020.109638→.
PMID: 32320860→.
Review.
ˍ
Kabir
TF, Kunos CA, Villano JL, Chauhan A.
Immunotherapy
for Medulloblastoma: Current Perspectives.
Immunotargets
Ther.
2020 Apr 20;9:57-77→.
doi: 10.2147/ITT.S198162→.
PMID: 32368525→.
Review.
ˍ
Westhoff
MA, Baisch T, Herbener VJ, Karpel-Massler G, Debatin KM, Strobel
H.
Comment
in Response to "Temozolomide in Glioblastoma Therapy: Role of
Apoptosis, Senescence and Autophagy etc. by B.
Kaina".
Biomedicines.
2020 Apr 20;8(4):E93→.
doi: 10.3390/biomedicines8040093→.
PMID: 32326020→.
Comment.
ˍ
REFERS
TO:
Kaina
B.,Temozolomide in Glioblastoma Therapy: Role of Apoptosis,
Senescence and Autophagy. Comment on Strobel et al., Temozolomide
and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines
2019, 7, 69. Biomedicines. 2019 Nov 11;7(4):90→.
doi: 10.3390/biomedicines7040090→.
PMID: 31717973→.
Comment.
ˍ
IN
TURN REFERRING TO:
Strobel
H, et al.,Temozolomide and Other Alkylating Agents in Glioblastoma
Therapy.
Biomedicines.
2019 Sep 9;7(3):69→.
doi: 10.3390/biomedicines7030069→.
PMID: 31505812→.
Review.
ˍ
Islam
SU, Shehzad A, Ahmed MB, Lee YS.
Intranasal
Delivery of Nanoformulations: A Potential Way of Treatment for
Neurological Disorders.
Molecules.
2020 Apr 21;25(8):E1929→.
doi: 10.3390/molecules25081929→.
PMID: 32326318→.
Review.
ˍ
Porfidia
A, Giordano M, Sturiale CL, D'Arrigo S, Donadini MP, Olivi A,
Ageno W, Pola R.
Risk
of intracranial bleeding in patients with primary brain cancer
receiving therapeutic anticoagulation for venous thromboembolism:
A meta-analysis.
Brain
Behav.
2020 Apr 21;e01638→.
doi: 10.1002/brb3.1638→.
PMID: 32314875→.
Meta-analysis.
ˍ
Schulte
JD, Aghi MK, Taylor JW.
Anti-angiogenic
therapies in the management of glioblastoma.
Chin
Clin Oncol.
2020 Apr 21, 2021;cco.2020.03.06→.
doi: 10.21037/cco.2020.03.06→.
PMID: 32389001→.
Review.
ˍ
Hanz
SZ, Adeuyan O, Lieberman G, Hennika T.
Clinical
trials using molecular stratification of pediatric brain
tumors.
Transl
Pediatr. 2020 Apr 23;9(2):144-156→.
doi: 10.21037/tp.2020.03.04→.
PMID: 32477915→.
Review.
ˍ
Thompson
EM, Ashley D, Landi D.
Current
medulloblastoma subgroup specific clinical trials.
Transl
Pediatr. 2020 Apr 23;9(2):157-162→.
doi: 10.21037/tp.2020.03.03→.
PMID: 32477916→.
Review.
ˍ
Mi
Y, Guo N, Luan J, Cheng J, Hu Z, Jiang P, Jin W, Gao X.
The
Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma
Immune Suppressive Microenvironment.
Front
Immunol.
2020 Apr 24;11:737→.
doi: 10.3389/fimmu.2020.00737→.
PMID: 32391020→.
Review.
ˍ
Shu
C, Li Q.
Current
advances in PD-1/PD-L1 axis-related tumour-infiltrating immune
cells and therapeutic regimens in glioblastoma.
Crit
Rev Oncol Hematol.
2020 Apr 24;151:102965→.
doi: 10.1016/j.critrevonc.2020.102965→.
PMID: 32442903→.
Review.
ˍ
Warsi
NM, Zewude R, Karmur B, Pirouzmand N, Hachem L, Mansouri A.
The
Cost-Effectiveness of 5-ALA in High Grade Glioma Surgery: A
Quality-Based Systematic Review.
Can
J Neurol Sci.
2020 Apr 24;1-17→.
doi: 10.1017/cjn.2020.78→.
PMID: 32329422→.
Review.
ˍ
Wen
PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel
FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF,
DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY,
Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G,
Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D,
Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von
Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent
MJ.
Glioblastoma
in Adults: A Society for Neuro-Oncology (SNO) and European Society
of Neuro-Oncology (EANO) Consensus Review on Current Management
and Future Directions.
Neuro
Oncol.
2020 Apr 24;noaa106→.
doi: 10.1093/neuonc/noaa106→.
PMID: 32328653→.
Review.
ˍ
Mazurek
M, Grochowski C, Litak J, Osuchowska I, Maciejewski R, Kamieniak
P.
Recent
Trends of microRNA Significance in Pediatric Population
Glioblastoma and Current Knowledge of Micro RNA Function in
Glioblastoma Multiforme.
Int
J Mol Sci.
2020 Apr 27;21(9):3046→.
doi: 10.3390/ijms21093046→.
PMID: 32349263→.
Review.
ˍ
Ali
AS, Chen VE, Zurlo C, Taylor JM, Fernandez C, Shi W.
Target
treatment with stereotactic radiation for recurrent gliomas.
Chin
Clin Oncol.
2020 Apr 28;cco.2020.03.05→.
doi: 10.21037/cco.2020.03.05→.
PMID: 32389000→.
Review.
ˍ
Kirstein
A, Schmid TE, Combs SE.
The
Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma
Multiforme.
Cancers
(Basel).
2020 Apr 28;12(5):E1099→.
doi: 10.3390/cancers12051099→.
PMID: 32354046→.
Review.
ˍ
Marron
JM, Kyi K, Appelbaum PS, Magnuson A.
Medical
Decision-Making in Oncology for Patients Lacking Capacity.
Am
Soc Clin Oncol Educ Book.
2020 Apr 28;40:1‐11→.
doi: 10.1200/EDBK_280279→.
PMID: 32347758→.
Review.
ˍ
Cuccia
F, Mortellaro G, Ognibene L, Craparo G, Lo Casto A, Ferrera G.
Salvage
Re-irradiation Options in Adult Medulloblastoma: A Case Report and
Review of the Literature.
In
Vivo.
2020 Apr 29;34(3):1283-1288→.
doi: 10.21873/invivo.11903→.
PMID: 32354920→.
Review.
ˍ
Garbayo
E, Pascual-Gil S, Rodríguez-Nogales C, Saludas L,
Estella-Hermoso de Mendoza A, Blanco-Prieto MJ.
Nanomedicine
and drug delivery systems in cancer and regenerative
medicine.
WIREs
Nanomed Nanobiotechnol.
2020 Apr 29;e1637→.
doi: 10.1002/wnan.1637→.
PMID: 32351045→.
Review.
ˍ
Yan
C, Kong X, Gong S, Liu F, Zhao Y.
Recent
advances of the regulation roles of MicroRNA in glioblastoma.
Int
J Clin Oncol.
2020 Apr 29;25(7):1215-1222→.
doi: 10.1007/s10147-020-01685-y→.
PMID: 32347433→.
Review.
ˍ
Zacharia
BE, Eichberg DG, Ivan ME, Hanft S, Boockvar JA, Isildak H,
Mansouri A, Komotar RJ, D'Amico RS.
Letter:
Surgical Management of Brain Tumor Patients in the COVID-19
Era.
Neurosurgery.
2020 Apr 29;87(2):E197-E200→.
doi: 10.1093/neuros/nyaa162→.
PMID: 32347942→.
Letter
to the editor, Guidelines.
ˍ
Ferraris
C, Cavalli R, Panciani PP, Battaglia L.
Overcoming
the Blood-Brain Barrier: Successes and Challenges in Developing
Nanoparticle-Mediated
Drug Delivery Systems for the Treatment of Brain Tumours.
Int
J Nanomedicine.
2020 Apr 30;15:2999-3022→.
doi: 10.2147/IJN.S231479→.
PMID: 32431498→.
Review.
ˍ
Kim
SK, Moon J, Cho JM, Kim KH, Kim SH, Kim YI, Kim YZ, Kim HS, Dho
YS, Park JS, Park JE, Seo Y, Sung KS, Song JH, Wee CW, Yoon WS,
Yoon HI, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang
K, Park CK, Lee YS, Gwak HS; KSNO Guideline Working Group.
A
National Consensus Survey for Current Practice in Brain Tumor
Management I: Antiepileptic Drug and Steroid Usage.
Brain
Tumor Res Treat.
2020 Apr 30;8(1):1-10→.
doi: 10.14791/btrt.2020.8.e5→.
PMID: 32390348→.
Survey.
ˍ
Kim
SK, Yoon HI, Yoon WS, Cho JM, Moon J, Kim KH, Kim SH, Kim YI, Kim
YZ, Kim HS, Dho YS, Park JS, Park JE, Seo Y, Sung KS, Song JH, Wee
CW, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang K,
Park CK, Lee YS, Gwak HS; KSNO Guideline Working Group.
A
National Consensus Survey for Current Practice in Brain Tumor
Management II: Diffuse Midline Glioma and Meningioma.
Brain
Tumor Res Treat.
2020 Apr 30;8(1):11-19→.
doi: 10.14791/btrt.2020.8.e6→.
PMID: 32390349→.
Survey.
ˍ
Kim
SK, Park JE, Kim KH, Cho JM, Moon J, Yoon WS, Kim SH, Kim YI, Kim
YZ, Kim HS, Dho YS, Park JS, Yoon HI, Seo Y, Sung KS, Song JH, Wee
CW, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang K,
Park CK, Lee YS, Gwak HS; KSNO Guideline Working Group.
A
National Consensus Survey for Current Practice in Brain Tumor
Management III: Brain Metastasis and Primary Central Nervous
System Lymphoma.
Brain
Tumor Res Treat.
2020 Apr 30;8(1):20-28→.
doi: 10.14791/btrt.2020.8.e7→.
PMID: 32390350→.
Survey.
ˍ